Publication: 2305

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 33 (35) 4167-4175
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
This study was also supported in part by National Heart, Lung, and Blood Institute along with contributions from Genzyme Inc. This study was presented in part as an oral presentation at the 2012 American Society of Hematology Meeting in Atlanta, GA
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
814  
Children:
None
Program:
OGC
Primary Committee:
Transplant
Sec. Committees:
Leukemia    
Pharmas:
 
Grants:
U10CA180821, U10CA180882, 1U10CA180850, 1U10CA180867, 1U10CA180858, 1U10CA180833, 1U10CA180790, 1U10CA180836, 1U10CA180838, 1U10CA180791, 1U10CA180836, U10 HL069294, U24 CA076518, U10 CA180821, U10 CA180858, U10 HL069334, U10 CA180836, U10 HL109137, U10 CA180791, U10 CA180850, U10 CA180790, U10 CA180882, U10HL069294, U10 CA180833, U10CA180821, U10 CA180867, U10 CA180838, U10 HL069315  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-WI013   
Study
CALGB-100103
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Bone1, Hema7, ORIGINAL REPORTS, Hematologic Malignancy